IRIS
BRISIGOTTI, VALERIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.644
EU - Europa 1.595
AS - Asia 1.435
SA - Sud America 323
AF - Africa 114
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 7.115
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.573
SG - Singapore 480
IT - Italia 334
VN - Vietnam 330
CN - Cina 303
RU - Federazione Russa 266
BR - Brasile 257
FR - Francia 168
SE - Svezia 148
DE - Germania 137
IE - Irlanda 135
UA - Ucraina 128
HK - Hong Kong 101
GB - Regno Unito 81
FI - Finlandia 71
CI - Costa d'Avorio 56
IN - India 53
TR - Turchia 36
DK - Danimarca 33
CA - Canada 32
ZA - Sudafrica 30
BD - Bangladesh 27
MX - Messico 25
NL - Olanda 23
AR - Argentina 21
JP - Giappone 18
KR - Corea 17
MA - Marocco 17
IQ - Iraq 16
BE - Belgio 14
ES - Italia 13
PL - Polonia 13
EC - Ecuador 11
CL - Cile 10
PK - Pakistan 10
ID - Indonesia 7
VE - Venezuela 7
AT - Austria 6
JM - Giamaica 6
PY - Paraguay 6
UZ - Uzbekistan 6
CO - Colombia 5
EG - Egitto 5
PH - Filippine 5
CZ - Repubblica Ceca 4
HU - Ungheria 4
TH - Thailandia 4
CH - Svizzera 3
EU - Europa 3
HR - Croazia 3
LT - Lituania 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
JO - Giordania 2
KE - Kenya 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
SM - San Marino 2
UY - Uruguay 2
AI - Anguilla 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
IL - Israele 1
KG - Kirghizistan 1
LB - Libano 1
LC - Santa Lucia 1
LY - Libia 1
MT - Malta 1
NI - Nicaragua 1
PR - Porto Rico 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 7.115
Salva come PNG Salva come JPEG
Città #
Ashburn 542
Chandler 372
Singapore 310
Dallas 222
Des Moines 186
Fairfield 173
San Jose 168
Jacksonville 140
Dublin 135
New York 116
Boardman 114
Ho Chi Minh City 99
Hong Kong 96
Wilmington 86
Hanoi 85
Council Bluffs 83
Seattle 83
The Dalles 83
Woodbridge 74
Houston 68
Beijing 66
Cambridge 59
Los Angeles 58
Munich 58
Abidjan 55
Lawrence 52
Princeton 52
Ann Arbor 50
Lauterbourg 50
Moscow 45
San Mateo 41
Helsinki 35
Centro 31
Buffalo 26
Turin 26
São Paulo 25
London 24
Milan 24
Turku 24
Ancona 23
Orem 23
Santa Clara 23
Pune 22
San Diego 22
Shanghai 21
Da Nang 20
Guangzhou 19
Haiphong 18
Johannesburg 18
Chicago 17
Hefei 16
Chennai 14
Tolentino 14
Brooklyn 13
Brussels 13
Marche 13
Tokyo 13
Wuhan 13
Denver 12
Rome 12
Montreal 10
Poplar 10
Warsaw 10
Washington 10
Miano 9
Phoenix 9
Ascoli Piceno 8
Frankfurt am Main 8
Hải Dương 8
Manchester 8
Stockholm 8
Baghdad 7
Biên Hòa 7
Boston 7
Columbus 7
Menlo Park 7
Norwalk 7
Nuremberg 7
Atlanta 6
Cagliari 6
Guarulhos 6
Kilburn 6
Piscataway 6
Rio de Janeiro 6
San Francisco 6
Campinas 5
Cape Town 5
Curitiba 5
Huskvarna 5
Itaquaquecetuba 5
Salt Lake City 5
San Bernardo 5
Surrey 5
Wuxi 5
Amsterdam 4
Bắc Ninh 4
Can Tho 4
Gainesville 4
Goiânia 4
Hangzhou 4
Totale 4.653
Salva come PNG Salva come JPEG
Nome #
Paraoxonase-2: A potential biomarker for skin cancer aggressiveness 321
I polimorfismi genetici nel melanoma cutaneo 217
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study 189
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 159
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 155
Differential expression of nicotinamide n-methyltransferase in cutaneous keratoacanthoma and squamous cell carcinoma: an immunohistochemical study 153
Involvement of the oral cavity in psoriasis: results of a clinical study 152
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 151
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 149
Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways 149
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 149
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 144
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 142
Alexandrite laser as an adjuvant therapy in the management of mild to moderate hidradenitis suppurativa: A controlled prospective clinical study 139
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 138
Differential immunohistochemical expression of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 138
Familial lupus panniculitis: two cases, same diagnosis, what evolution? 135
Dermoscopic features of conjunctival melanocytic lesions 134
Primary Dermal Melanoma: A Rare Clinicopathological Variant Mimicking Metastatic Melanoma 132
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 132
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 129
Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient: a random association? 127
Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature 127
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 126
The transitioning from conventional therapy to biological treatment in psoriatic patients: STRATOS, a project of Marche Region 126
Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone 125
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 123
Reticulated acanthoma with sebaceous differentiation 122
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 121
Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa 119
Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- alpha Inhibitors 119
Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines 119
Relapsing acute generalized exanthematous pustolosis: a guess. 118
The potential effect of the tumour necrosis factor-α inhibitors on vitamin D status in psoriatic patients 116
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic 116
Topical application of fumaric acid esters improves appearance of nail psoriasis 115
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 113
Renbök phenomenon in a Down syndrome patient with hidradenitis suppurativa and alopecia areata 112
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 111
Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study 109
Mycosis Fungoides-like Eruption and Infliximab 108
The switching from a biological therapy to another biologic agent in psoriatic patients: the experience of PsOMarche group 108
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 108
Expression of nicotinamide N-methyltransferase in non-melanoma skin cancers 107
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa 105
Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature 105
Immunohistochemical analysis of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 105
Immunohistochemical expression of nicotinamide N-methyltransferase in cutaneous basal and squamous cell carcinomas 104
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 104
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa 101
Systemic antibiotic therapy in hidradenitis suppurativa: a review on treatment landscape and current issues 95
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 92
Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis. 91
Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study 91
Phototherapy in Dermatology 86
Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa 77
Successful use of dalbavancin in the management of severe hidradenitis suppurativa 69
Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation. 46
Totale 7.273
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.359
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 0 32
2021/2022425 12 75 22 9 16 24 12 40 23 11 72 109
2022/20231.054 81 125 82 89 56 273 3 57 193 5 68 22
2023/2024601 89 11 57 63 71 141 11 27 4 43 7 77
2024/20251.014 155 81 29 19 39 40 88 33 202 67 140 121
2025/20263.029 289 169 238 310 374 212 508 261 249 217 86 116
Totale 7.273